Binish Chudgar News Today

Hercessi is used fora variety of cancer treatments.

The FDA has approved Hercessi for the adjuvant treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

The FDA has approved trastuzumab-strf for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or GEJ adenocarcinoma.

MAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible for the development, manufacturing, and supply of the Etanercept biosimilar.

/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited ("Intas") for the...

The English-language Greek City Times, quoting unnamed sources, said during talks between Prime Minister Modi and his Greek counterpart Kyriakos Mitsotakis the Indian leader 'expressed the country's interest in acquiring ports in Greece'

Nimish, Binish and Urmish Chudgars firm is today one of the most valuable unlisted Indian companies at Rs 58,000 crore.

Global phase III with 605 patients from the US and eight European countries demonstrates therapeutic equivalence and safety between Stelara and DMB-3115 Aims to submit marketing authorization

/PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care...

/PRNewswire/ -- Prestige Biopharma Limited (KRX: 950210, hereafter referred to as "Prestige") and Intas Pharmaceuticals Limited (hereafter referred to as...